Literature DB >> 21875253

The present scenario of cervical cancer control and HPV epidemiology in India: an outline.

J Giftson Senapathy1, P Umadevi, P S Kannika.   

Abstract

OBJECTIVE: To give a clear picture with epidemiological evidence about the present scenario of cervical cancer control and HPV in India.
DESIGN: Review of published studies, concentrating on recent systematic reviews, meta-analyses and large prospective studies. CONCLUSIONS AND RECOMMENDATIONS: Cervical cancer is unique among cancers in that it can largely be prevented through screening and removal of precursor lesions. It is the second most common cancer among women worldwide and is the most common malignancy in developing countries, particularly in India. Nowadays, cervical screening for women is necessary because there are no signs and symptoms of cervical precancers. The establishment of a prevention program is urgently required considering both screening and vaccination. But most women in India do not have access to effective screening programmes. It has been estimated that in India, even with a major effort to expand cytology services, it will not be possible to screen even one-fourth of the population once in a lifetime in the near future. New HPV vaccines will also help prevent HPV infection and the precancerous changes that lead to cervical cancer. The focus on detection and prevention of cervical cancer must be emphasized in a highly populated country like India to prevent its extensive spread.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875253

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

1.  Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.

Authors:  Sanghyuk S Shin; Catherine L Carpenter; Maria L Ekstrand; Qiao Wang; Surbhi Grover; Nicola M Zetola; Kartik Yadav; Sanjeev Sinha; Adeline M Nyamathi
Journal:  Int J STD AIDS       Date:  2019-02-27       Impact factor: 1.359

2.  ALEX1 may be a novel biomarker for human cervical squamous cell carcinoma.

Authors:  Fan Zeng; Kui Liao; Jiayan Wu; Yue Gao; Haiyu Li; Jianjun Fan; Hantao Zhang; Yun Li; Xin Bai; Geili Liu; Fangzhou Song
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers.

Authors:  Nicolás Vergara; Monserrat Balanda; Wilma Hidalgo; Héctor San Martín; Alexis Aceituno; Francisco Roldán; Tania Villalón; Melissa Hott; Gloria Espinoza; Andrea Quiero; María T Valenzuela; Eugenio Ramírez
Journal:  Med Microbiol Immunol       Date:  2017-12-14       Impact factor: 3.402

4.  Profile of cervical cancer patients attending Tertiary Care Hospitals of Mangalore, Karnataka: A 4 year retrospective study.

Authors:  Aadhya Sharma; Vaman Kulkarni; Unnikrishnan Bhaskaran; Meher Singha; Saad Mujtahedi; Anshul Chatrath; Mallika Sridhar; Rekha Thapar; P Prasanna Mithra; Nithin Kumar; Ramesh Holla; B B Darshan; Avinash Kumar
Journal:  J Nat Sci Biol Med       Date:  2017 Jan-Jun

5.  Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.

Authors:  Sureewan Bumrungthai; Kavita Munjal; Shirish Nandekar; Kumarasen Cooper; Tipaya Ekalaksananan; Chamsai Pientong; Mark Francis Evans
Journal:  J Transl Med       Date:  2015-07-25       Impact factor: 5.531

6.  Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains.

Authors:  Krishna P Singh; Neeraj Verma; Bashir A Akhoon; Vishal Bhatt; Shishir K Gupta; Shailendra K Gupta; Suchi Smita
Journal:  3 Biotech       Date:  2016-01-27       Impact factor: 2.406

Review 7.  HPV Vaccination in India: Critical Appraisal.

Authors:  Aruna Nigam; Pikee Saxena; Anita S Acharya; Archana Mishra; Swaraj Batra
Journal:  ISRN Obstet Gynecol       Date:  2014-03-11

8.  Anti-proliferative and apoptotic effects of Ziziphus Jujube on cervical and breast cancer cells.

Authors:  Mohammad Reza Abedini; Nafiseh Erfanian; Habibollah Nazem; Sara Jamali; Reyhane Hoshyar
Journal:  Avicenna J Phytomed       Date:  2016 Mar-Apr

9.  Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer.

Authors:  Wenjing Wang; Yanhua Shi; Jing Li; Wei Cui; Baozhi Yang
Journal:  Biosci Rep       Date:  2016-04-05       Impact factor: 3.840

10.  Unusual presentation of metastatic carcinoma cervix with clinically silent primary identified by (18)F-flouro deoxy glucose positron emission tomography/computed tomography.

Authors:  Raja Senthil; Ranjan Kumar Mohapatra; Shripriya Srinivas; Mouleeswaran Koramadai Sampath; Sumati Sundaraiya
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.